@johnmcclean_ie @Bernp1953P @bealelab @InCytometry @greg_travis @JohnGee55117754 @mgmgomes1 @ScienceShared @CovidSerology @zorinaq @GidMK @BillHanage I have seen 0'3% at more places than just one article from CEBM. Like those 6 papers: https://t.co/T2HPo
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-prevalence déjà observé en 🇪🇸 n'est pas de bon augure pour l'immunité collective! Humoral Immune Response to SARS-CoV-2 in Iceland | NEJM h
As it turns out approximately half of the total number of actual infections were found as demonstrated by later population testing for antibodies. https://t.co/2ltaQOogrY & https://t.co/ZYYYP8Le0A But most people don’t live in the North Atlantic! What
RT @Meltem3440: Böyle güzel haberlere ihtiyacımız var.
@Bernp1953P @greg_travis @Craig_1_1_7 @johnmcclean_ie @bealelab @InCytometry @JohnGee55117754 @mgmgomes1 @ScienceShared @zorinaq @GidMK @BillHanage Antibody decline and plateau is normal after recovery from infection. The antibodies remain detectable for a
@johnmcclean_ie @Bernp1953P @greg_travis @JohnGee55117754 @mgmgomes1 @bealelab @ScienceShared @CovidSerology @InCytometry Real the whole thread here: https://t.co/KdtN0OzetN Some (small) studies find as low as ~60% develop antibodies. But you are right, th
RT @drmiguelmarcos: Los anticuerpos frente a SARS-CoV-2 en pacientes infectados de Covid-19 no descendieron durante un periodo de seguimien…
@CHOMES102 @mgmgomes1 @AtomsksSanakan @AVG_Joseph96 @zorinaq ¿? Have you read those six here above? I can't see them. https://t.co/Y8u48g60ev https://t.co/PfLBgXObEx https://t.co/JmFlzoCgxb https://t.co/wjgrXcTuaa https://t.co/dtultUNG9X https://t.
@CHOMES102 @mgmgomes1 @AtomsksSanakan @AVG_Joseph96 @zorinaq Again. IFR 0'3% 👇 https://t.co/T2HPoWuDqj
@CHOMES102 @mgmgomes1 IFR 0'3% https://t.co/T2HPoWuDqj
Any comment @MattHancock @BorisJohnson @JuliaHB1 @danwootton @Iromg
Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis.' 👉https://t.co/e4JtpiFgyK #UKRTC #sarscov2 #covid19 ht
@UnintendedCons5 Incorrect. Studies have shown that 60-91% of people develop antibodies, and the most reliable (larger) studies are closer to 80-90% than 60%: https://t.co/KdtN0OQPSn Therefore this data suggests IFR estimates are correct within 10-20%
@waynesyrek @AzWarren @_stah Huh, turns out not everyone who gets infected has detectable antibodies, so maybe the % infected could exceed the positivity rate of serology tests. https://t.co/pVmqOVAAeV
Antiviral antibodies against #SARS-CoV-2 did not decline within 4 months after diagnosis. We estimate that the risk of death from infection was 0.3% and that 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by qPCR. #covid19 https://t
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
@PetesTinyCalves @EricTopol My comment didn't say anything at all about intervention. Or allude in any way to lockdown. But now that you mention it, the only thing we need to do is protect the vulnerable! (which is mostly those >70 years) https://t
@medwatch_de @berlinerzeitung @wznewsline Es gibt ja noch die Island-Studie, die landet auch bei IFR von 0,3%. https://t.co/P28KZ5PP8k Den Diamond Princess Datensatz gibt es auch noch als interessant in dieser Hinsicht. Würde mich wundern, wenn 1% das letz
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @DrDavidKatz: “Our results indicate that antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. We estimate risk…
RT @allbouncesurrey: #ODX....wonderful....bring on next week 👀👀😷📈 https://t.co/6pxiSKFF5h
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
@SapiensWell It's a bit exaggerated. More precisely the German study found 28.2% to 39.9% may not develop antibodies. The average of the 2 towns is 34%. But 2 much larger studies found only 9-15% may not develop antibodies: https://t.co/KdtN0OzetN
@tefltheatre @djbradshaw64 IFR in Iceland estimated at 0.3% in this https://t.co/LXFPj97nwQ A lot lower than many estimates from other countries, but 6 times higher than 0.05%......
@Ramonnnnn @matuk @juanmoreb Entonces habría que hacer un estudio serio de seroprevalencia. Te recomiendo que leas el artículo del NEJM que te he adjuntado y entiendas la diferencia en niveles de evidencia para afirmar cosas. Una carta al editor con 40-50
@Ramonnnnn @matuk Imaginaba que ibas a poner ese artículo. Para ver un artículo del NEJM, te recomendaría: https://t.co/vyabXCXoSc
RT @CovidSerology: Follow up studies up to 5 and 6 months (https://t.co/Xfn0dYusTW) confirm this observation even in PCR cohorts with mild…
RT @allbouncesurrey: #ODX....wonderful....bring on next week 👀👀😷📈
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
#ODX....wonderful....bring on next week 👀👀😷📈
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis.' 👉https://t.co/e4JtpiFgyK #UKRTC #sarscov2 #covid19 h
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
@jackieohughes @JOEWV @Bill43111 @mfgrp @SWAtlasHoover If infection only affords protection 4 months post-infection, herd immunity can not realistically be achieved. Suggesting it can is irresponsible. https://t.co/hKjn9NMUCr
Es un estudio muy interesante, ya que testaron a un número importante de personas. No obstante, este 44% corresponde a estimaciones de personas que se cree que si se infectaron pero a las cuales no se hizo una RT-PCR para la detección de #SARSCoV2
RT @MonicaGandhi9: Let's keep tweeting each other all the good immunity papers we can find & the duration of protection expected until we g…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
RT @_bgzorn_: Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infecta…
Great study/Gran estudio: 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by PCR. Un 44% de los infectados con SARS-CoV-2 en Islandia no se diagnosticaron por PCR. Humoral Immune Response to SARS-CoV-2 in Iceland | NEJM https://t.co/0
RT @drmiguelmarcos: Los anticuerpos frente a SARS-CoV-2 en pacientes infectados de Covid-19 no descendieron durante un periodo de seguimien…
@KlausMl67471449 @1900HO @Karl_Lauterbach Lt. einer von Island beauftragten Studie sind es bisher 4 Monate. Viel mehr kann an das der denn doch kurzen Zeit nicht erwarten. Ist ansonsten aber auch eine sehr interessante Studie. https://t.co/J65U474ME1
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @realstock100: #ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
#ODX. Looks like the test is registered. Next rns is probably going to be orders imo. #AIM https://t.co/Ugu0MGiWjk
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
Antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. We estimate that the risk of death from infection was 0.3% and that 44% of persons infected with SARS-CoV-2 in Iceland were not diagnosed by qPCR https://t.co/cJKkSwUs
RT @CRAIGMCKEE82: #ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped…
#ODX looks like the evidence is all there! Antibodies testing is going to be the game changer that it was initially hoped it would be. Immunity passports all lining up
Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis.' 👉https://t.co/e4JtpiFgyK #UKRTC #sarscov2 #covid19
Trotz der sehr heterogenen Gruppe kann man die IFR von 0,3% über alle und von 4,4% bei den über 70-jährigen auch für Deutschland annehmen, solange es keine aussagekräftigen Studien in 🇩🇪 gibt. Nur 44% der Infektionen nicht mit PCR festgestellt. https://t.c
A Different Spatiotemporal Seroprevalence Outcome Depending Upon Which SARS-CoV-2 Antibodies Are Tested https://t.co/X0aVt4CsS6 #ExpatNotesLux #COVID19 #nCoV #Coronavirus @ResearchLux @uni_lu @sante_lu @LNS_Lux @LIH_Luxembourg @LISERinLUX @LIST_Luxembou
RT @CovidSerology: Follow up studies up to 5 and 6 months (https://t.co/Xfn0dYusTW) confirm this observation even in PCR cohorts with mild…
Follow up studies up to 5 and 6 months (https://t.co/Xfn0dYusTW) confirm this observation even in PCR cohorts with mild and asymptomatic disease. 4/n https://t.co/6bVoF77Bw4
@DoubleEph The very rapid seroreversion seen in the data doesn't make sense virologically and its at odds with other data. 5 months from peak antibodies were still detectable in 91% of PCR confirmed infections in Iceland. https://t.co/MWUyWhAal9
@PatriceDerome @MadPharmacist1 @bibinhafcsm @Rakiko_Hime Études scientifiques sur le IFR: Danmark 0.08% https://t.co/qlM19abbiL Brésil 0.17% https://t.co/09rdOkAiNk Slovénie 0.16% https://t.co/9eNu9vNSAz Icelande 0.1% (moins de 70 ans) https://t.co
RT @CRAIGMCKEE82: #ODX #ukrtc another study showing that immunity can last after infection! No decline in 4 months!
RT @CRAIGMCKEE82: #ODX #ukrtc another study showing that immunity can last after infection! No decline in 4 months! https://t.co/cKbqGuLZFj
@jzpinski Przykład takich empirycznych badań https://t.co/4oLdfLbqXG
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis #ODX
@hkultala @OsmoSoininvaara Esim. New England Journal of Medicine https://t.co/YqtYDeGQcI
RT @Cicerorecic1: @IkNet @ItsMssS @thierrybaudet Goeie genade. Het houdt niet op vandaag. Nadat eerst Van Dissel bevestigt dat PCR-test gee…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
@IkNet @ItsMssS @thierrybaudet Goeie genade. Het houdt niet op vandaag. Nadat eerst Van Dissel bevestigt dat PCR-test geen uitslag geeft wat betreft besmetting en aangeeft dat COVID-19 niet ernstig besmettelijk is, bevestigt nu eindelijk Rutte dat het mort
#ukrtc #odx @OmegaDiagnostic @Abingdon_Health @bbi_solutions @cigahealthcare
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…